BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17822667)

  • 21. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Src protein-tyrosine kinase structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the Src family kinase Hck without SH3-linker release.
    Lerner EC; Trible RP; Schiavone AP; Hochrein JM; Engen JR; Smithgall TE
    J Biol Chem; 2005 Dec; 280(49):40832-7. PubMed ID: 16210316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
    Chen S; Brier S; Smithgall TE; Engen JR
    Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
    Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
    Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain.
    Hong E; Shin J; Kim HI; Lee ST; Lee W
    J Biol Chem; 2004 Jul; 279(28):29700-8. PubMed ID: 15056653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.
    Young MA; Gonfloni S; Superti-Furga G; Roux B; Kuriyan J
    Cell; 2001 Apr; 105(1):115-26. PubMed ID: 11301007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
    Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
    J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation.
    Hu KQ; Settleman J
    EMBO J; 1997 Feb; 16(3):473-83. PubMed ID: 9034330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abl N-terminal cap stabilization of SH3 domain dynamics.
    Chen S; Dumitrescu TP; Smithgall TE; Engen JR
    Biochemistry; 2008 May; 47(21):5795-803. PubMed ID: 18452309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.
    Severin A; Joseph RE; Boyken S; Fulton DB; Andreotti AH
    J Mol Biol; 2009 Apr; 387(3):726-43. PubMed ID: 19361414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.
    LaFevre-Bernt M; Sicheri F; Pico A; Porter M; Kuriyan J; Miller WT
    J Biol Chem; 1998 Nov; 273(48):32129-34. PubMed ID: 9822689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of intra versus intermolecular self-association within the regulatory domains of Rlk and Itk.
    Laederach A; Cradic KW; Fulton DB; Andreotti AH
    J Mol Biol; 2003 Jun; 329(5):1011-20. PubMed ID: 12798690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and spectroscopic characterization of the human protein tyrosine kinase-6 SH3 domain.
    Koo BK; Kim MH; Lee ST; Lee W
    J Biochem Mol Biol; 2002 May; 35(3):343-7. PubMed ID: 12297019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
    Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
    Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts.
    Briggs SD; Smithgall TE
    J Biol Chem; 1999 Sep; 274(37):26579-83. PubMed ID: 10473622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the SH3-SH2 domain linker sequence on the structure of Hck kinase.
    Meiselbach H; Sticht H
    J Mol Model; 2011 Aug; 17(8):1927-34. PubMed ID: 21110053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
    Tsui T; Miller WT
    Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 Å resolution.
    Thakur MK; Kumar A; Birudukota S; Swaminathan S; Tyagi R; Gosu R
    Biochem Biophys Res Commun; 2016 Sep; 478(2):637-42. PubMed ID: 27480927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.